Tax for Startups

Unlocking Growth: A Comprehensive Guide to R&D Tax Incentives Under Section 35 of the Indian Income Tax Act

Published 2026-06-16 · Themis Lexsol Consulting — Indian Startup Law & Advisory

Innovation is the lifeblood of any thriving startup. In India, the Income Tax Act, 1961, recognizes this by offering significant tax benefits for Research and Development (R&D) activities through Section 35. This advisory aims to demystify these incentives, empowering Indian founders, investors, and legal professionals to leverage them for sustainable growth.

Understanding Section 35: The Core of R&D Tax Incentives

Section 35 of the Income Tax Act, 1961, provides for the deduction of expenditure incurred on scientific research. This section is crucial for businesses that invest in innovation and technological advancement. The primary objective is to encourage companies to undertake R&D, thereby fostering a culture of innovation within the Indian economy. The benefits are substantial, often allowing for deductions exceeding the actual expenditure incurred, making it a powerful tool for tax planning and cost reduction.

The Act categorizes R&D expenditure into different types, each with specific eligibility criteria and deduction mechanisms:

  • Expenditure on Scientific Research Related to the Business: This includes revenue expenditure incurred on scientific research related to the business carried on by the taxpayer.
  • Capital Expenditure on Scientific Research: This covers expenditure on building, machinery, plant, and equipment used for scientific research.
  • Payments to Research Associations, Universities, and Colleges: Contributions made to approved institutions for scientific research are also eligible for deductions.
  • Payments to a National Laboratory or University for Social Science or Statistical Research: Similar to scientific research, contributions for social science or statistical research are also incentivized.

Types of R&D Expenditure and Their Deductions

Section 35 offers various forms of deductions based on the nature of R&D expenditure:

1. Weighted Deduction for In-house R&D (Section 35(1)(i) & (ii)):

  • Revenue Expenditure: Companies undertaking in-house R&D activities can claim a weighted deduction of 150% of the expenditure incurred on scientific research related to their business. This means for every ₹100 spent, ₹150 can be deducted from taxable income.
  • Capital Expenditure: Capital expenditure incurred on scientific research related to the business is also eligible for a deduction. Typically, 100% of such expenditure is deductible in the year it is incurred.

2. Weighted Deduction for Sponsored Research (Section 35(2AA)):

  • Payments made to a university, college, or specified research institution for the purpose of carrying out scientific research related to the business are eligible for a weighted deduction of 200% of the amount paid. This significantly boosts the incentive for collaboration.

3. Deduction for Payments to Research Associations (Section 35(1)(iii)):

  • Payments made to a research association, university, college, or other specified institution, which has been approved by the prescribed authority for the purpose of carrying out scientific research, are eligible for a deduction of 100% of the amount paid.

4. Deduction for Payments for Social Science or Statistical Research (Section 35(1)(iia)):

  • Expenditure incurred on scientific research on social science or statistical research, when paid to a national laboratory, university, or Indian Institute of Technology, is eligible for a deduction of 100% of the amount paid.

5. Weighted Deduction for R&D Facilities (Section 35(1)(iv) & 35(2AB)):

  • Section 35(2AB) specifically provides a weighted deduction of 200% for expenditure on scientific research on or after April 1, 2017, by way of capital expenditure on building, machinery, plant, etc., used for scientific research. This is a significant incentive for setting up dedicated R&D infrastructure.

Eligibility Criteria and Compliance Requirements

To avail the benefits under Section 35, businesses must meet certain criteria and adhere to specific compliance procedures:

  • Nature of Expenditure: The expenditure must be demonstrably for scientific research related to the business. This requires clear documentation and a well-defined R&D strategy.
  • Approval of Institutions: For sponsored research or contributions to research associations, the receiving institution must be approved by the prescribed authority (e.g., the Secretary, Department of Scientific and Industrial Research).
  • Documentation: Meticulous record-keeping is paramount. This includes invoices, payment receipts, research proposals, progress reports, and any other evidence substantiating the R&D activities.
  • Audit Requirements: In certain cases, the accounts of the R&D expenditure may need to be audited by a chartered accountant as per the provisions of the Income Tax Act.
  • Certification: For specific deductions, a certificate from the prescribed authority may be required to confirm the nature and extent of R&D activities.
  • Compliance with SEBI and FEMA: While Section 35 is primarily governed by the Income Tax Act, startups operating under SEBI regulations (e.g., for fundraising) or dealing with foreign exchange transactions under FEMA provisions must ensure their R&D activities and related expenditures are compliant with these overarching frameworks. For instance, if R&D expenditure involves foreign currency payments or intellectual property licensing, FEMA regulations on outward remittances and foreign investments would need to be considered.

Strategic Importance for Startups and Investors

Section 35 offers a powerful strategic advantage for Indian startups and a compelling reason for investors to consider them:

  • Enhanced Cash Flow: The substantial deductions directly reduce a company's tax liability, freeing up capital that can be reinvested in further R&D, scaling operations, or talent acquisition.
  • Competitive Advantage: By making R&D more affordable, these incentives enable startups to invest more aggressively in innovation, thereby gaining a competitive edge in the market.
  • Attracting Investment: For venture capital and private equity firms, startups that can effectively leverage R&D tax incentives present a more attractive investment proposition due to their improved profitability and growth potential. Investors often look for businesses with strong IP and a clear path to innovation, which Section 35 directly supports.
  • IP Development: The incentives encourage the creation and protection of intellectual property (IP), which is a critical asset for startups and a key valuation driver for investors.
  • Long-Term Sustainability: By fostering a culture of continuous innovation, Section 35 contributes to the long-term sustainability and growth of startups, aligning with the goals of both founders and investors.

Practical Implications

  • Startups should proactively identify and track all R&D related expenditures to maximize eligible deductions.
  • Engage with tax professionals early to ensure proper classification and documentation of R&D activities.
  • Collaborate with approved research institutions to leverage higher deduction percentages.
  • Investors should inquire about a startup's R&D tax incentive strategy during due diligence.
  • Maintain robust internal controls and record-keeping systems for all R&D related financial transactions.
  • Ensure compliance with SEBI regulations regarding disclosure of tax benefits and FEMA provisions for any international R&D collaborations or technology transfers.

Common Pitfalls

  • Misclassifying general business expenses as R&D expenditure.
  • Inadequate documentation leading to disallowance of claims.
  • Failure to obtain necessary approvals for research institutions or activities.
  • Not considering the interplay of R&D tax incentives with other tax provisions or compliance requirements like SEBI and FEMA.
  • Delaying the claim of deductions, leading to missed opportunities.

Key Takeaways

  • Section 35 of the Income Tax Act, 1961, offers significant tax benefits for R&D expenditure.
  • Weighted deductions of up to 200% are available for certain R&D activities and capital expenditures.
  • Meticulous documentation and adherence to eligibility criteria are crucial for successful claims.
  • These incentives are a powerful tool for enhancing cash flow and fostering innovation in startups.
  • Investors should consider R&D tax incentives as a positive indicator of a startup's growth potential and strategic planning.
  • Ensure alignment with SEBI and FEMA regulations for holistic compliance.
Disclaimer: This article provides general information and should not be considered as professional legal or tax advice. Themis Lexsol Consulting does not accept liability for reliance on the content of this article.